🇺🇸 FDA
Patent

US 11028362

Decellularized human amniotic membrane for cell delivery, cell culture and inflammation prevention

granted A61KA61K35/28A61K35/39

Quick answer

US patent 11028362 (Decellularized human amniotic membrane for cell delivery, cell culture and inflammation prevention) held by The Regents of the University of California expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K35/28, A61K35/39, A61K35/50, A61K38/488